- Category
- Micro (2024-25)
- Udyam number
- UDYAM-PB-12-0026524

About Glactor Pharma India Private Limited
Data last updated:
Glactor Pharma India Private Limited is a private limited company based in Ludhiana, Punjab, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 18 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2016PTC040093. Its GSTIN is 03AAGCG2939K1ZJ (Punjab).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pratibha Mishra and Narayan Parsad Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 120 – A Civil City Near Shiv Durga Mata Mandir, Ludhiana, Punjab, India – 141001.
As per the financials filed for FY 2025, the company reported a revenue of ₹32.82 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹5,526 (net margin 0.2%) and EBITDA of ₹32,730 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 3% over five years.
Glactor Pharma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-12-0026524). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website glactorpharma.com.
Company details
Recognitions & Rankings of Glactor Pharma India
Contact details
Glactor Pharma India Private Limited's registered office is in Ludhiana, Punjab. Its website is glactorpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH.No. 120 – A Civil City Near Shiv Durga Mata Mandir, Ludhiana, Punjab, India – 141001
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Glactor Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Glactor Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Glactor Pharma India Private Limited, buy the company report.
Financials of Glactor Pharma India Private Limited
FY 2025 filings availableGlactor Pharma India Private Limited reported revenue of ₹32.82 Lakh (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 2% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32,730 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5,526 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glactor Pharma India Private Limited, buy the company report.
Board of directors of Glactor Pharma India Private Limited
Glactor Pharma India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narayan Parsad Mishra Also directs: Peiskos Labs India Private Limited | Additional Director | 09 Dec 2019 | 6 Years 10 Months | Current |
| Pratibha Mishra Also directs: Peiskos Labs India Private Limited | Director | 18 Feb 2016 | 10 Years 8 Months | Current |
Peer comparison
Glactor Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genexis Biotech Private Limited | ₹32.88 Lakh (FY 2024) | 15.0% | Vadodara, Gujarat, India | |||
| Protein Design Private Limited | ₹32.87 Lakh (FY 2024) | 31.0% | Bangalore, Karnataka, India | |||
| Filix Organics Private Limited | ₹32.86 Lakh (FY 2018) | 85.0% | Hyderabad, Telangana, India | |||
| Normo Helth Private Limited | ₹32.84 Lakh (FY 2025) | -23.0% | Jalgaon, Maharashtra, India | |||
| Medscape Pharma Private Limited | ₹32.83 Lakh (FY 2025) | -83.0% | Chennai, Tamil Nadu, India | |||
| Glactor Pharma India Private Limitedthis company | ₹32.82 Lakh (FY 2025) | ₹5,526 | 0.2% | 2.0% | Ludhiana, Punjab, India | |
| Zyzir Pharmaceuticals Private Limited | ₹32.75 Lakh (FY 2023) | 25.0% | Hyderabad, Telangana, India | |||
| Chirayu Gases Private Limited | ₹32.74 Lakh (FY 2025) | -29.0% | Bhopal, Madhya Pradesh, India | |||
| Promois Life Sciences & Animal Health Crae Products Private Limited | ₹32.7 Lakh (FY 2025) | -63.0% | Kanpur, Uttar Pradesh, India | |||
| Thinkgenix Biotech Private Limited | ₹32.66 Lakh (FY 2024) | 27.0% | Khurda, Odisha, India | |||
| Orgvedic Private Limited | ₹32.64 Lakh (FY 2025) | 131.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Glactor Pharma India Private Limited, buy the company report.
Auditor
Glactor Pharma India Private Limited is audited by PARAM GOYAL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PARAM GOYAL & ASSOCIATES | FY 2017 | 031163N |
Shareholding
The shareholding of Glactor Pharma India Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Glactor Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Glactor Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glactor Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Glactor Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAGCG2939K1ZJ | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Glactor Pharma India Private Limited, buy the company report.
Recent activity
Glactor Pharma India Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Kamaljeet ceased to be Director on 10 Dec 2019.
Frequently asked questions
Glactor Pharma India is an active private limited company based in Ludhiana, Punjab, India. The company works in chemical products, within the chemicals industry. It was incorporated on 18 February 2016 (10+ years old) and is registered under CIN U24232PB2016PTC040093.
Glactor Pharma India has 2 current directors:
- Narayan Parsad Mishra - Additional Director
- Pratibha Mishra - Director
The latest financial statements of Glactor Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Glactor Pharma India is 03AAGCG2939K1ZJ, registered in Punjab.
The CIN (Corporate Identification Number) of Glactor Pharma India is U24232PB2016PTC040093. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glactor Pharma India was incorporated on 18 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Glactor Pharma India by revenue are Genexis Biotech Private Limited, Protein Design Private Limited, Filix Organics Private Limited, Normo Helth Private Limited, Medscape Pharma Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kamaljeet ceased to be Director on 10 Dec 2019. Narayan Parsad Mishra was appointed as Additional Director on 09 Dec 2019. Gursewak Singh ceased to be Director on 22 Apr 2019. Glactor Pharma India has 4 board changes on record in total.
Yes, Glactor Pharma India is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-12-0026524).
Glactor Pharma India can be reached through the website glactorpharma.com. Its registered office is in Ludhiana, Punjab, India.
The registered office of Glactor Pharma India is at H.No. 120 – A Civil City Near Shiv Durga Mata Mandir, Ludhiana, Punjab, India – 141001.

